insights_auto
Why is MGX down 7.69%?
Dive Deeperchevron_right
MGX:NASDAQ
Metagenomi Therapeutics Inc
$1.02
arrow_downward
-7.69%(-0.085) 1D
Oct 2, 4:00:01 PM GMT-4 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for MGX...
Open
$1.09
High
$1.10
Low
$1.02
Mkt. cap
38.36M
Avg. vol.
149.22K
Volume
0.00
52-wk high
$3.95
52-wk low
$1.02
EPS
-$2.49
Shares outstanding
37.78M
No. of employees
113
Open
$1.09
High
$1.10
Low
$1.02
Mkt. cap
38.36M
Avg. vol.
149.22K
Volume
0.00
52-wk high
$3.95
52-wk low
$1.02
EPS
-$2.49
Shares outstanding
37.78M
No. of employees
113
News stories
From web sources and news partners
Quartz
·
11 minutes ago
Dow futures slip as Treasury yields stay high Monday
bloomingbit
·
15 minutes ago
US Corporate Profit Run Continues as S&P 500 Q3 Net Income Estimate Rises 2.2%
Barron's
·
7 minutes ago
S&P 500 Futures Decline in Premarket Trading; Vaxcyte, PTC Lead
www.marketscreener.com
·
5 hours ago
Panmure Liberum sets 2027 year-end S&P 500 target at 5,000
About Metagenomi Therapeutics Inc
CEO-
Employees113
Founded2016
HeadquartersEmeryville, California, United States
SectorBiotechnology
Websitemetagenomi.co